Search - tctmd.com

Displaying 141 - 160 of 230

Sort: Relevancy | Date

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

Presentation

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Presenter: Martin Werner

February 19, 2014

News Industry News

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

February 13, 2014

News Daily News

FDA批准新支架用于透析通路狭窄的治疗

January 27, 2014

News Daily News

FDA Approves Novel Stent Graft for Dialysis-Access Stenosis

January 27, 2014

News Daily News

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

January 22, 2014

Presentation ISET 2014

Single-Center Experience with Zilver PTX Drug-eluting Stent for Treatment of SFA Lesions and In-stent Re-Stenoses

Presenter: Melanie Schernthaner

January 20, 2014

Presentation ISET 2014

Ultrasound Enhanced Delivery of Paclitaxel to SFA/POP for CLI Patients

Presenter: Roberto Gandini

January 20, 2014

Presentation ISET 2014

Safety and Efficacy of the EverFlex Stent in Long Complex SFA lesions: Sub-group Analysis of the DURABILITY II Study

Presenter: Mahmood Razavi

January 20, 2014

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

L.A. McKeown

January 20, 2014

Presentation TCT 2013

IN.PACT SFA II

Presenter: Peter Schneider

October 31, 2013

Presentation TCT 2013

Get Real - DES Technologies are Better Suited Than DCB for SFA Indication!

Presenter: Michael Dake

October 31, 2013

Presentation TCT 2013

Case #1: SFA Revascularization via Popliteal Access

Presenter: Mirvat Alasnag

October 31, 2013

Presentation TCT 2013

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Presenter: Thomas Zeller

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Presenter: James Joye

October 27, 2013

Presentation TCT 2013

Treating SFA Intervention Complicated by Dissection: A Novel Approach Using "Tack"

Presenter: Marianne Brodmann

October 27, 2013

Presentation TCT 2013

The Economics of SFA Intervention

Presenter: Mark Burket

October 27, 2013

Presentation TCT 2013

The Data-Driven Role of Atherectomy in SFA Disease Today and Tomorrow: LIBERTY 360 and the JET Registry

Presenter: Lawrence Garcia

October 27, 2013

Presentation TCT 2013

Stenting Is the First-line Treatment for SFA Disease!

Presenter: J. Michael Bacharach

October 27, 2013

Advertisement

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

FDA批准新支架用于透析通路狭窄的治疗

FDA Approves Novel Stent Graft for Dialysis-Access Stenosis

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

Single-Center Experience with Zilver PTX Drug-eluting Stent for Treatment of SFA Lesions and In-stent Re-Stenoses

Ultrasound Enhanced Delivery of Paclitaxel to SFA/POP for CLI Patients

Safety and Efficacy of the EverFlex Stent in Long Complex SFA lesions: Sub-group Analysis of the DURABILITY II Study

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

IN.PACT SFA II

Get Real - DES Technologies are Better Suited Than DCB for SFA Indication!

Case #1: SFA Revascularization via Popliteal Access

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Innovation in Intervention: Perspectives from Industry

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Treating SFA Intervention Complicated by Dissection: A Novel Approach Using "Tack"

The Economics of SFA Intervention

The Data-Driven Role of Atherectomy in SFA Disease Today and Tomorrow: LIBERTY 360 and the JET Registry

Stenting Is the First-line Treatment for SFA Disease!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content